Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
Iacopo Chiodini, Davide Gatti, Davide Soranna, Daniela Merlotti, Christian Mingiano, Angelo Fassio, Giovanni Adami, Alberto Falchetti, Cristina Eller-Vainicher, Maurizio Rossini, Luca Persani, Antonella Zambon, Luigi Gennari
Frontiers in Public Health, doi:10.3389/fpubh.2021.736665
Background: Several studies suggest an association between serum 25-hydroxyvitamin D (25OHD) and the outcomes of Severe Acute Respiratory Syndrome Corona-Virus-2 (SARS-CoV-2) infection, in particular Coronavirus Disease-2019 (COVID-19) related severity and mortality. The aim of the present meta-analysis was to investigate whether vitamin D status is associated with the COVID-19 severity, defined as ARDS requiring admission to intensive care unit (ICU) or mortality (primary endpoints) and with the susceptibility to SARS-CoV-2 and COVID-19-related hospitalization (secondary endpoints). Methods: A search in PubMed, ScienceDirect, Web of Science, Google Scholar, Scopus, and preprints repositories was performed until March 31th 2021 to identify all original observational studies reporting association measures, or enough data to calculate them, between Vitamin D status (insufficiency <75, deficiency <50, or severe deficiency <25 nmol/L) and risk of SARS-CoV-2 infection, COVID-19 hospitalization, ICU admission, or death during COVID-19 hospitalization. Findings: Fifty-four studies (49 as fully-printed and 5 as pre-print publications) were included for a total of 1,403,715 individuals. The association between vitamin D status and SARS-CoV2 infection, COVID-19 related hospitalization, COVID-19 related ICU admission, and COVID-19 related mortality was reported in 17, 9, 27, and 35 studies, respectively. Severe deficiency, deficiency and insufficiency of vitamin D were all associated with ICU admission (odds ratio [OR], 95% confidence intervals [95%CIs]:
SUPPLEMENTARY MATERIAL The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh. 2021.736665/full#supplementary-material Supplementary Figure 1
Conflict of Interest: IC received speaker fees from HRA Pharma, Corcept Therapeutics, Eli-Lilly, Amgen, and UCB. DG received honoraria and/or speaker fees from Amgen, Celgene, Eli-Lilly, MSD-italia, Organon, and UCB. DM received honoraria form UCB Pharma and Savio Pharma. GA has received advisory board honoraria and consultancy fees from Theramex. CE-V has received advisory board honoraria from Kyowa Kirin, Sandoz. MR has received advisory board honoraria, consultancy fees, and/or speaker fees from Abiogen, Amgen, Abbvie, BMS, Eli-Lilly, Galapagos, Menarini, MSD, Novartis, Pfizer, Sandoz, Theramex, and UCB. LP received consultancy fees, and/or speaker fees from Merck, Sandoz, Recordati. LG received honoraria from Sandoz and Kyowa Kirin. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
Abdollahi, Salehinia, Badeli, Karimi, Gandomkar et al., The biochemical parameters and Vitamin D levels in ICU patients with COVID-19: a cross-sectional study, Endocr Metab Immune Disord Drug Targets,
doi:10.2174/1871530321666210316103403Abrishami, Dalili, Torbati, Asgari, Arab-Ahmadi et al., Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study, Eur J Nutr,
doi:10.1007/s00394-020-02411-0Agraz-Cibrian, U-Is, 25-Dihydroxyvitamin D3 induces formation of neutrophil extracellular trap-like structures and modulates the transcription of genes whose products are neutrophil extracellular trap-associated proteins: a pilot study, Steroids,
doi:10.1016/j.steroids.2018.11.001Ahmadpoor, Rostaing, Why the immune system fails to mount an adaptive immune response to a COVID-19 infection, Transpl Int,
doi:10.1111/tri.13611Aihara, Azuma, Akaike, Ikeda, Yamashita et al., Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice, J Biol Chem,
doi:10.1074/jbc.M404865200Alguwaihes, Sabico, Hasanato, Sofani, Megdad et al., Severe vitamin D deficiency is not related to SARS CoV 2 infection but may increase mortality risk in hospitalized adults: a retrospective casecontrol study in an Arab Gulf country, Aging Clin Exp Res,
doi:10.1007/s40520-021-01831-0Alipio, Vitamin D supplementation could possibly improve clinical outcomes of patients infected with coronavirus-2019 (COVID-2019), SSRN Electron J,
doi:10.2139/ssrn.3571484Ames, Grant, Willett, Does the high prevalence of vitamin D deficiency in African Americans contribute to health disparities?, Nutrients,
doi:10.3390/nu13020499Amrein, Scherkl, Hoffmann, Neuwersch-Sommeregger, Köstenberger et al., Vitamin D deficiency 2.0: an update on the current status worldwide, Eur J Clin Nutr,
doi:10.1038/s41430-020-0558-yAngelidi, Belanger, Lorinsky, Karamanis, Chamorro-Pareja et al., Vitamin D status is associated with in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients, Mayo Clin Proc,
doi:10.1016/j.mayocp.2021.01.001Anjum, Suleman, Afridi, Yasmeen, Shah et al., None, Pakistan Journal of Medical and Health Sciences
Annweiler, Corvaisier, Gautier, Dubée, Legrand et al., Vitamin D supplementation associated to better survival in hospitalized frail elderly COVID-19 patients: the GERIA-COVID quasi-experimental study, Nutrients,
doi:10.3390/nu12113377Arvinte, Singh, Marik, Serum levels of vitamin C and Vitamin D in a cohort of critically ill COVID-19 patients of a North American Community hospital intensive care unit in may 2020: a pilot study, Med Drug Discov,
doi:10.1016/j.medidd.2020.100064Barassi, Pezzilli, Mondoni, Rinaldo, Davì et al., Vitamin D in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with non-invasive ventilation support, Panminerva Med,
doi:10.23736/S0031-0808.21.04277-4Basaran, Adas, Gokden, Turgut, Yildirmak et al., The relationship between vitamin D and the severity of COVID-19, Bratisl Med J,
doi:10.4149/BLL_2021_034Bennouar, Cherif, Kessirac, Bennouar, Abdia, Vitamin D deficiency and low serum calcium as predictors of poor prognosis in patients with severe COVID-19, J Am Coll Nutr,
doi:10.1080/07315724.2020.1856013Borsche, Glauner, Mendel, COVID-19 mortality risk correlates inversely with Vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/mL 25(OH)D3: Results of a systematic review and meta-analysis, Nutrients,
doi:10.3390/nu13103596Bouillon, Marcocci, Carmeliet, White, Hughes et al., Skeletal and extraskeletal actions of Vitamin D: current evidence and outstanding questions, Endocr Rev,
doi:10.1210/er.2018-00126Brandão, Chiamolera, Biscolla, Lima, Junior et al., No association between vitamin D status and COVID-19 infection in São Paulo, Brazil, Arch Endocrinol Metab,
doi:10.20945/2359-3997000000343Campi, Gennari, Merlotti, Mingiano, Frosali et al., Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect Dis,
doi:10.1186/s12879-021-06281-7Carpagnano, Lecce, Quaranta, Zito, Buonamico et al., Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest,
doi:10.1007/s40618-020-01370-xCastillo, Costa, Barrios, Díaz, Miranda et al., Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: a pilot randomized clinical study, J Steroid Biochem Mol Biol,
doi:10.1016/j.jsbmb.2020.105751Cereda, Bogliolo, Klersy, Lobascio, Masi et al., Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital, Clin Nutr,
doi:10.1016/j.clnu.2020.10.055Chang, Ding, Freund, Johnson, Schwarz et al., Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System, medRxiv,
doi:10.1101/2020.07.03.20145581Charoenngam, Shirvani, Reddy, Vodopivec, Apovian et al., Association of Vitamin D status with hospital morbidity and mortality in adult hospitalized patients with COVID-19, Endocr Pract,
doi:10.1016/j.eprac.2021.02.013Cianferotti, Bertoldo, Bischoff-Ferrari, Bruyere, Cooper et al., Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis, Endocrine,
doi:10.1007/s12020-017-1290-9Cortegiani, Catalisano, Ippolito, Giarratano, Absalom et al., Retracted papers on SARS-CoV-2 and COVID-19, Br J Anaesth,
doi:10.1016/j.bja.2021.01.008Cuñat, Ojeda, Calvo, Vitamin D deficiency in critically ill patients diagnosed with COVID−19. Are we doing enough? A retrospective analysis of 226 patients, Research Square,
doi:10.21203/rs.3.rs-30390/v1D'avolio, Avataneo, Manca, Cusato, Nicolò et al., 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients,
doi:10.3390/nu12051359Dancer, Parekh, Lax, Souza, Zheng et al., Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax,
doi:10.1136/thoraxjnl-2014-206680Darling, Ahmadi, Ward, Harvey, Alves et al., Vitamin D status, body mass index, ethnicity and COVID-19: Initial analysis of the first-reported UK Biobank COVID-19 positive cases (n 580) compared with negative controls, medRxiv,
doi:10.1101/2020.04.29.20084277Demir, Demir, Aygun, Vitamin D deficiency is associated with COVID-19 positivity and the severity of the disease, J Med Virol,
doi:10.1002/jmv.26832Faniyi, Lugg, Faustini, Webster, Duffy et al., Vitamin D status and seroconversion for COVID-19 in UK healthcare workers who isolated for COVID-19 like symptoms during the 2020 pandemic, Eur Respir J,
doi:10.1101/2020.10.05.20206706Faul, Kerley, Love, 'neill, Cody et al., Vitamin d deficiency and ards after sars-cov-2 infection, Ir Med J
Ferrari, Locatelli, No significant association between vitamin D and COVID-19. a retrospective study from a northern Italian hospital, Int J Vitam Nutr Res,
doi:10.1024/0300-9831/a000687Gaudio, Murabito, Agodi, Montineri, Castellino et al., Vitamin D levels are reduced at the time of hospital admission in sicilian SARS-CoV-2-positive patients, Int J Environ Res Public Health,
doi:10.3390/ijerph18073491Gavioli, Miyashita, Hassaneen, Siau, An evaluation of serum 25-Hydroxy vitamin D levels in patients with COVID-19 in New York City, J Am Coll Nutr,
doi:10.1080/07315724.2020.1869626Griffin, Hewison, Hopkin, Kenny, Quinton et al., Vitamin D and COVID-19: evidence and recommendations for supplementation, R Soc Open Sci,
doi:10.1098/rsos.201912Hansdottir, Monick, Hinde, Lovan, Look et al., Respiratory epithelial cells convert inactive vitamin d to its active form: potential effects on host defense, J Immunol,
doi:10.4049/jimmunol.181.10.7090Hars, Mendes, Serratrice, Herrmann, Gold et al., Sex-specific association between vitamin D deficiency and COVID-19 mortality in older patients, Osteoporos Int,
doi:10.1007/s00198-020-05677-6Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr Clin Res Rev,
doi:10.1016/j.dsx.2020.04.050Hernández, Nan, Fernandez-Ayala, García-Unzueta, Hernández-Hernández et al., Vitamin d status in hospitalized patients with Sars-Cov-2 infection, J Clin Endocrinol Metab,
doi:10.1210/clinem/dgaa733Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley et al., Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab,
doi:10.1210/jc.2011-0385Huang, Soleimani, Herasevich, Pinevich, Pennington et al., Clinical characteristics, treatment, and outcomes of critically ill patients with COVID-19: a scoping review, Mayo Clin Proc,
doi:10.1016/j.mayocp.2020.10.022Infante, Buoso, Pieri, Lupisella, Nuccetelli et al., Low Vitamin D status at admission as a risk factor for poor survival in hospitalized patients with COVID-19: an Italian retrospective study, J Am Coll Nutr,
doi:10.1080/07315724.2021.1877580Jain, Chaurasia, Sengar, Singh, Mahor et al., Analysis of vitamin D level among asymptomatic and critically ill COVID -19 patients and its correlation with inflammatory markers, Sci Rep,
doi:10.1038/s41598-020-77093-zJayawardena, Jeyakumar, Francis, Misra, Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries, Diabetes Metab Syndr,
doi:10.1016/j.dsx.2021.03.006Jeng, Yamshchikov, Judd, Blumberg, Martin et al., Alterations in vitamin D status and antimicrobial peptide levels in patients in the intensive care unit with sepsis, J Transl Med,
doi:10.1186/1479-5876-7-28Jevalikar, Mithal, Singh, Sharma, Farooqui et al., Lack of association of baseline 25-hydroxyvitamin D levels with disease severity and mortality in Indian patients hospitalized for COVID-19, Sci Rep,
doi:10.1038/s41598-021-85809-yJolliffe, Camargo, Jr, Sluyter, Aglipay et al., Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol
Karahan, Katkat, Impact of serum 25(OH) Vitamin D level on mortality in patients with COVID-19 in Turkey, J Nutr Heal Aging,
doi:10.1007/s12603-020-1479-0Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One,
doi:10.1371/journal.pone.0239252Kazemi, Mohammadi, Aghababaee, Golzarand, Clark et al., Association of Vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis, Adv Nutr,
doi:10.1093/advances/nmab012Laird, Rhodes, Kenny, Vitamin D and inflammation: potential implications for severity of COVID-19, Ir Med J
Li, Cao, Yang, Zhang, Xu et al., Metabolic healthy obesity, Vitamin D status, and risk of COVID-19, Aging Dis,
doi:10.14336/AD.2020.1108Ling, Broad, Murphy, Pappachan, Pardesi-Newton et al., High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study, Nutrients,
doi:10.3390/nu12123799Liu, Sun, Wang, Zhang, Zhao et al., Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis, Int J Infect Dis,
doi:10.1016/j.ijid.2020.12.077Lohia, Nguyen, Patel, Kapur, Exploring the link between vitamin D and clinical outcomes in COVID-19, Am J Physiol Endocrinol Metab,
doi:10.1152/ajpendo.00517.2020Luo, Liao, Shen, Li, Cheng, Vitamin D deficiency is inversely associated with COVID-19 incidence and disease severity in Chinese People, J Nutr,
doi:10.1093/jn/nxaa332Macaya, Espejo, Valls, Fernández-Ortiz, Del Castillo et al., Interaction between age and vitamin d deficiency in severe COVID-19 infection, Nutr Hosp,
doi:10.20960/nh.03193Maghbooli, Sahraian, Ebrahimi, Pazoki, Kafan et al., Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS One,
doi:10.1371/journal.pone.0239799Manios, Moschonis, Lambrinou, Tsoutsoulopoulou, Binou et al., A systematic review of vitamin D status in southern European countries, Eur J Nutr,
doi:10.1007/s00394-017-1564-2Mardani, Alamdary, Nasab, Gholami, Ahmadi et al., Association of vitamin D with the modulation of the disease severity in COVID-19, Virus Res,
doi:10.1016/j.virusres.2020.198148Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583Mazziotti, Lavezzi, Brunetti, Mirani, Favacchio et al., Humanitas COVID19 task force. Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19, J Endocrinol Invest,
doi:10.1007/s40618-021-01535-2Mccullough, Lehrer, Amend, Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience, Steroid Biochem Mol Biol,
doi:10.1016/j.jsbmb.2018.12.010Meltzer, Best, Zhang, Vokes, Arora et al., Association of Vitamin D status and other clinical characteristics with COVID-19 test results, JAMA Netw Open,
doi:10.1001/jamanetworkopen.2020.19722Mendy, Apewokin, Wells, Morrow, Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 Patients, medRxiv,
doi:10.1101/2020.06.25.20137323Merzon, Tworowski, Gorohovski, Vinker, Cohen et al., Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study, FEBS J,
doi:10.1111/febs.15495Mok, Ng, Ahidjo, Lee, Loe et al., Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis, bioRxiv,
doi:10.1101/2020.06.21.162396Munshi, Hussein, Toraih, Elshazli, Jardak et al., Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J Med Virol,
doi:10.1002/jmv.26360Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a single high dose of Vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial, JAMA,
doi:10.1001/jama.2020.26848Nidadavolu, Walston, Underlying vulnerabilities to the cytokine storm and adverse COVID-19 outcomes in the aging immune system, J Gerontol A Biol Sci Med Sci,
doi:10.1093/gerona/glaa209Nogues, Ovejero, Pineda-Moncusí, Bouillon, Arenas et al., Calcifediol treatment and COVID-19-related outcomes, J Clin Endocrinol Metab,
doi:10.1210/clinem/dgab405Ohsawa, Koyama, Yamamoto, Hirosawa, Kamei et al., 1alpha,25-dihydroxyvitamin D(3) its potent synthetic analogs downregulate tissue factor upregulate thrombomodulin expression in monocytic cells, Circulation,
doi:10.1161/01.CIR.102.23.2867Orchard, Baldry, Nasim-Mohi, Monck, Saeed et al., Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients, Clin Chem Lab Med,
doi:10.1515/cclm-2020-1567Page, Mckenzie, Bossuyt, Boutron, Hoffmann et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ,
doi:10.1016/j.ijsu.2021.105906Pal, Banerjee, Bhadada, Shetty, Singh et al., Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis, J Endocrinol Invest,
doi:10.1007/s40618-021-01614-4Panagiotou, Tee, Ihsan Y Athar, Marchitelli, Kelly, Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity, Clin Endocrinol,
doi:10.1111/cen.14276Pereira, Damascena, Azevedo, De Almeida Oliveira, Da et al., Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr,
doi:10.1080/10408398.2020.1841090Pinzon, Pradana, Vitamin D deficiency among patients with COVID-19: case series and recent literature review, Trop Med Health,
doi:10.1186/s41182-020-00277-wPizzini, Aichner, Sahanic, Böhm, Egger et al., Impact of vitamin d deficiency on COVID-19-a prospective analysis from the COVID registry, Nutrients,
doi:10.3390/nu12092775Quesada-Gomez, Entrenas-Castillo, Bouillon, Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections, J Steroid Biochem Mol Biol,
doi:10.1016/j.jsbmb.2020.105719Quraishi, Bittner, Blum, Hutter, Camargo, Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery, JAMA Surg,
doi:10.1001/jamasurg.2013.3176Quraishi, Bittner, Christopher, Camargo, Vitamin D status and community-acquired pneumonia: results from the third National Health and Nutrition Examination Survey, PLoS One,
doi:10.1371/journal.pone.0081120Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger, Vitamin D deficiency and outcome of COVID-19 patients, Nutrients,
doi:10.3390/nu12092757Raharusuna, Priambada, Budiarti, Patterns of mortality and vitamin D : an indonesian study, medRxiv,
doi:10.2139/ssrn.3585561Raisi-Estabragh, Mccracken, Bethell, Cooper, Cooper et al., Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank, J Public Heal,
doi:10.1093/pubmed/fdaa095Reid, Knox, Talwar, Reilly, Blackwell et al., Acute changes in the systemic inflammatory response is associated with transient decreases in circulating 25-hydroxyvitamin D concentrations following elective knee arthoplasty, Ann Clin Biochem,
doi:10.1016/S1744-1161(10)70509-3Ricci, Pagliuca, 'ascanio, Innammorato, Vitis et al., Circulating Vitamin D levels status and clinical prognostic indices in COVID-19 patients, Respir Res,
doi:10.1186/s12931-021-01666-3Smet, Smet, Herroelen, Gryspeerdt, Martens, Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics, Am J Clin Pathol,
doi:10.1101/2020.05.01.20079376Tehrani, Khabiri, Moradi, Mosavat, Khabiri, Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality, Clin Nutr ESPEN,
doi:10.1016/j.clnesp.2021.01.014Tort, Mercado, Cuazitl, Puente Nieto, Pérez, La deficiencia de vitamina D es un factor de riesgo de mortalidad en pacientes con COVID-19, Rev Sanid Milit,
doi:10.35366/93773Vanegas-Cedillo, Bello-Chavolla, Ramírez-Pedraza, Encinas, Carrión et al., Serum Vitamin 1 D levels are associated with increased COVID-19 2 severity and mortality independent of visceral adiposity, medRxiv
Vasheghani, Jannati, Baghaei, Rezaei, Marjani, The association of 25 (OH) Vitamin D levels and severity and outcome of COVID-19: a crosssectional study, Sci Rep,
doi:10.21203/rs.3.rs-141034/v1Vassiliou, Jahaj, Pratikaki M Orfanos, Dimopoulou, Kotanidou, Low 25-Hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a Greek ICU cohort, Nutrients,
doi:10.3390/nu12123773Walk, Vitamin D -contrary to vitamin K -does not associate with clinical outcome in hospitalized COVID-19 patients, medRxiv,
doi:10.1101/2020.11.07.20227512Wells, Shea, Connell, Peterson, Welch et al., The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system, Mol Med Rep,
doi:10.3892/mmr.2017.7546Ye, Tang, Liao, Shaw, Deng et al., Does serum Vitamin D level affect COVID-19 infection and its severity?-A case-control study, J Am Coll Nutr,
doi:10.1080/07315724.2020.1826005
